| Nov 5 |
Johnson & Johnson Darzalex shows efficacy in early-stage multiple myeloma
|
| Nov 5 |
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
|
| Nov 5 |
With 73% ownership of the shares, Johnson & Johnson (NYSE:JNJ) is heavily dominated by institutional owners
|
| Nov 4 |
Is Johnson & Johnson (JNJ) the Best Pharma Stock to Buy Right Now?
|
| Nov 4 |
Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare
|
| Nov 1 |
Stocks that hedge funds moved from long to short in August - Jefferies
|
| Nov 1 |
Johnson & Johnson MedTech concludes enrolment for OMNY-AF trial pilot phase
|
| Nov 1 |
J&J Medtech CIO Larry Jones resigns
|
| Oct 31 |
The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction
|
| Oct 31 |
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions
|
